Shafique Virani

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

RXRX

Current role

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2023	Recursion Pharmaceuticals, Inc. (RXRX)	Former Chief Corporate Development Officer	$520,417	—	$908,463	$1,130,537	$208,442	$36,182	$2,804,040
2022	Recursion Pharmaceuticals, Inc. (RXRX)	Former Chief Corporate Development Officer	$488,333	—	$497,181	$588,894	$181,906	$11,600	$1,767,914
2021	Recursion Pharmaceuticals, Inc. (RXRX)	Former Chief Corporate Development Officer	$500,000	—	—	—	$175,000	$13,174	$688,174
2020	Recursion Pharmaceuticals, Inc. (RXRX)	Chief Corporate Development Office	$413,541	$13,000	—	$991,749	$28,158	$20,523	$1,466,974

No earnings-call appearances or filed executive changes recorded yet.